Glaxosmithkline Share News (GSK)

Novartis melanoma drug combination wins EU green light

LONDON, July 24 (Reuters) - European regulators on Friday recommended the use of a combination of Novartis's drugs Tafinlar and Mekinist for treating certain patients with melanoma, boosting prospects for medicines acquired from GlaxoSmithKline. The Swiss drugmaker said the U.S. Food and D

UPDATE 3-World's first malaria vaccine gets regulatory go-ahead, faces WHO review

* EU regulators back GSK's Mosquirix for babies in Africa * Product is first human vaccine against a parasitic disease * Mosquito-borne malaria infects 200 million people a year * WHO to assess vaccine in October before possible rollout (Adds WHO giving date for its review, WH

TOP NEWS SUMMARY: Anglo American To Wield Axe As Commodity Prices Tank

London open: FTSE 100 resilient in face of weak China, Eurozone PMIs

(ShareCast News) - Investors braved weaker than expected readings on Chinese and Eurozone manufacturing and lingering worries regarding Greece, allowing the top flight index to recover after dipping at the start of trading. As of 09:05 the Footsie was 7.34 points higher to end at 6,665.30. Stocks r

Glaxo's malaria vaccine clears final scientific hurdle

(ShareCast News) - Healthcare giant GlaxoSmithKline said its malaria vaccine has passed its last scientific hurdle, although the immunisation programme in sub-Saharan Africa could be still over 12 months away. On Thursday, the treatment, aimed at young children, was given a positive scientific opini

CORRECTED-World's first malaria vaccine gets go-ahead from EU regulators

(Corrects to remove reference to need for European Commission approval) * Vaccine developed by GlaxoSmithKline for babies in Africa * WHO will now decide whether to recommend vaccine for use * GSK scientist worked on the vaccine for almost 30 years By Kate Kelland, Health

LONDON BRIEFING: Pearson Leads FTSE 100 After FT Sale To Nikkei

UPDATE 1-World's first malaria vaccine gets go-ahead from EU regulators

* GSK's Mosquirix will be approved for babies in Africa * Vaccine is first human vaccine against parasitic disease * Mosquito-borne Malaria infects around 200 people a year * The disease killed 584,000 in 2013, most of them children (Adds quotes, bullets, details on pricing, i

GlaxoSmithKline Malaria Vaccine Gets Positive CHMP Opinion

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

BUZZ-GlaxoSmithKline: broker gloomy on margins ahead of Q2

** GlaxoSmithKline slips 1.4% as Morgan Stanley warns margins likely to decline 260 bp when drugmaker reports Q2 results on July 29 ** Margins pressure reflects continuous decline in sales of lung drug Advair and revamp of portfolio after big Novartis asset swap ** Broker says GSK's

Problematic diabetes drugs may protect against Parkinson's

LONDON, July 21 (Reuters) - Two problematic diabetes drugs associated with worrying side effects may reduce the risk of patients developing Parkinson's disease, offering a springboard for further research, scientists said on Tuesday. An analysis of more than 160,000 British diabetics found